Elevated Rate of Facial Paralysis Identified After Pfizer COVID-19 Booster in Elderly: FDA

Elevated Rate of Facial Paralysis Identified After Pfizer COVID-19 Booster in Elderly: FDA
A nurse prepares the Pfizer-BioNTech COVID-19 vaccine in a file image. Jeff Kowalsky/AFP via Getty Images
Zachary Stieber
Zachary Stieber
Senior Reporter
|Updated:
0:00

An elevated rate of Bell’s palsy, a type of facial paralysis, was identified among elderly people after COVID-19 vaccination with a Pfizer booster shot, U.S. regulators said in a new study.

The “small but statistically significant elevation” was detected after vaccination with Pfizer’s old booster shot, which is no longer available in the United States, researchers with the U.S. Food and Drug Administration (FDA) said in a preprint study.

Zachary Stieber
Zachary Stieber
Senior Reporter
Zachary Stieber is a senior reporter for The Epoch Times based in Maryland. He covers U.S. and world news. Contact Zachary at [email protected]
twitter
truth
Related Topics